Grifols
the Triturus immunoassay analyzer automates ELISA-format testing, positioned within Grifols's broader blood-and-plasma diagnostics portfolio alongside its immunohematology sample-processing systems.
- Country
- Spain
- Ticker
- NASDAQ:GRFS
NASDAQ:GRFS
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Automated ELISA analyzers | analytics-pat | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.